国产OMOM与进口GIVEN胶囊内镜的对比应用研究

发布时间：2018-05-10 12:16

本文选题：OMOM胶囊内镜 + SB2胶囊内镜　；参考：《遵义医学院》2017年硕士论文

【摘要】：目的:应用临床路径管理,对比研究国产OMOM与进口GIVEN SB2胶囊内镜临床应用的安全性及有效性。方法:将2013年8月至2016年8月期间接受胶囊内镜检查的67例受检者纳入研究,根据患者自愿原则选择胶囊内镜类型并进行分组,OMOM组60例,GIVEN组7例,两组均按设定的临床路径完成检查,终止检查后,将记录仪上的图片下载至专用工作站,由2名医师独立阅片回顾分析,分别记录胶囊内镜检查中的胃内转运时间和小肠内运行时间,统计两组全小肠检查完成率、病变检查率、阳性发现率,并将以上指标进行对比研究。结果:1.两组运用临床路径管理均安全的完成胶囊内镜检查,效果满意,无不良事件发生。2.转运时间:OMOM组与GIVEN组胶囊内镜平均胃转运时间分别为35.18±28.83min、42.00±49.04min,经t检验,P0.05,差异无统计学意义;平均小肠内运行时间分别为229.82±113.95min、149.86±70.70min,经t检验,P0.05,差异无统计学意义。3.胶囊内镜检查结果:OMOM组与GIVEN组胃镜干预率分别为10.00%、0,经Fisher精确检验,P0.05;全小肠检查完成率分别为98.33%、100%,经Fisher精确检验,P0.05;病变检出率分别为85.00%、71.43%,经Fisher精确检验,P0.05;阳性发现率分别为63.33%、71.43%,经Fisher精确检验,P0.05。结论:1.国产OMOM CE与进口GIVEN SB2 CE检查小肠疾病,其临床路径大同小异,在临床应用中诊断价值均高,安全性及患者耐受性均良好。2.国产OMOM CE体积、重量均较大、但价廉,通过胃(幽门)进入十二指肠在120分钟内干预率较高。3.进口GIVEN SB2胶囊内镜体积较小、重量较轻,较昂贵,通过胃(幽门)进入十二指肠的通过性较好。4.两组胶囊内镜平均小肠运行时间、全小肠检查完成率、病变检出率、阳性发现率均无明显差异。
[Abstract]:Objective: to compare the safety and efficacy of endoscopy with domestic OMOM and imported GIVEN SB2 capsule by clinical path management. Methods: from August 2013 to August 2016, 67 patients who received capsule endoscopy were included in the study. According to the voluntary principle of patients, the type of capsule endoscopy was selected and divided into OMOM group (n = 60) and GIVEN group (n = 7). The two groups completed the examination according to the set clinical path. After the examination was terminated, the pictures on the recorder were downloaded to the special workstation. The intragastric transit time and the intraintestinal operating time of capsule endoscopy were recorded, and the complete rate, pathological examination rate and positive detection rate of the two groups were counted, and the above indexes were compared. The result is 1: 1. The two groups completed capsule endoscopy safely by clinical path management. The results were satisfactory and no adverse events occurred. 2. 2. The mean translocation time of capsule endoscopes was 35.18 卤28.83 min and 42.00 卤49.04 min, respectively, and there was no significant difference between the two groups (P 0.05, P 0.05), and the mean intraintestinal operating time was 229.82 卤113.95 min, 149.86 卤70.70 min, respectively, and there was no significant difference between the two groups (P 0.05, P 0.05). The results of capsule endoscopy were as follows: the intervention rate of gastroscope was 10.00% in the GIVEN group and 10.00% in the control group, respectively, and the complete rate of the whole intestinal examination was 98.33% and 100%, respectively, and the positive detection rate was 71.43% by Fisher, respectively, and the positive detection rate was higher than that of the control group (P0.05), and the positive detection rate was higher than that of the control group (P < 0.05), and the positive detection rate was higher than that of the control group (P < 0.05). It's 63.33 and 71.43, which is exactly tested by Fisher. Conclusion 1. The clinical pathway of domestic OMOM CE and imported GIVEN SB2 CE is similar to that of imported GIVEN SB2 CE. The diagnostic value of domestic OMOM CE is high, and the safety and patient tolerance are good. 2. The volume and weight of domestic OMOM CE were large, but the price was low. The intervention rate of domestic OMOM CE entering duodenum through stomach (pylorus) was higher within 120 minutes. The imported GIVEN SB2 capsule endoscopy is smaller in volume, lighter in weight and more expensive, and the passage of the capsule through the stomach (pylorus) into the duodenum is better. 4. There was no significant difference between the two groups in the mean intestinal operation time, the complete rate of the whole intestinal examination, the detection rate of pathological changes and the positive detection rate.
【学位授予单位】：遵义医学院
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R57

【相似文献】